Bill > SB2336

This bill modifies the Texas Pharmaceutical Initiative by expanding the governing board from three to five members appointed by the governor, with new provisions for staggered six-year terms where approximately one-third of board members' terms expire every odd-numbered year. The bill requires the board to prepare and submit a comprehensive business plan by June 1 of each even-numbered year (instead of the previous one-time October 1, 2024 deadline) that details the initiative's organizational structure, implementation strategies, and service provisions. These services include establishing statewide pharmacy benefit manager services, creating a distribution network for prescription drugs, and developing advanced pharmaceutical capabilities such as manufacturing generic drugs, providing gene therapies, and supporting innovative drug research. The bill also mandates procedures for documenting conflicts of interest, identifying potential cost savings, and establishing conditions for state agency participation. Additionally, the bill provides specific instructions for the governor's initial board appointments, with staggered initial terms expiring in 2027, 2029, and 2031, and sets the act's effective date as September 1, 2025.

Health and Social Services

https://capitol.texas.gov/BillLookup/History.aspx?LegSess=89R&Bill=SB2336